CollPlant Biotechnologies Ltd. CLGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -39.66% | -63.41% | -28.11% | 1,996.94% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -39.66% | -63.41% | -28.11% | 1,996.94% | |
| Cost of Revenue | 203.23% | -29.41% | -65.30% | -65.50% | |
| Gross Profit | -6,414.29% | -22.22% | 97.56% | 517.67% | |
| SG&A Expenses | -12.61% | -21.54% | -18.57% | -4.47% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -18.35% | -22.43% | -27.88% | -16.35% | |
| Operating Income | 17.15% | 20.73% | 27.87% | 61.93% | |
| Income Before Tax | 18.55% | 17.30% | 20.50% | 65.39% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 18.55% | 17.30% | 20.50% | 65.39% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 18.55% | 17.30% | 20.50% | 65.39% | |
| EBIT | 17.15% | 20.73% | 27.87% | 61.93% | |
| EBITDA | 17.40% | 21.38% | 28.85% | 65.32% | |
| EPS Basic | 33.15% | 25.92% | 23.09% | 65.39% | |
| Normalized Basic EPS | 33.15% | 25.92% | 23.09% | -- | |
| EPS Diluted | 33.15% | 25.92% | 23.09% | 65.39% | |
| Normalized Diluted EPS | 33.15% | 25.92% | 23.09% | -- | |
| Average Basic Shares Outstanding | 21.83% | 11.62% | 3.37% | 0.02% | |
| Average Diluted Shares Outstanding | 21.83% | 11.62% | 3.37% | 0.02% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |